Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL149624 | 1.00 | MEN1 (0.39) | MEN1KMT2ATDP1 | |
| SCHEMBL297815 | 1.00 | MEN1 (0.39) | MEN1KMT2ATDP1 | |
| SCHEMBL555525 | 1.00 | MEN1 (0.39) | MEN1KMT2ATDP1 | |
| SCHEMBL2402774 | 0.95 | MEN1 (0.36) | MEN1KMT2ATDP1 | |
| SCHEMBL1280064 | 0.90 | MEN1 (0.39) | MEN1KMT2ATDP1 | |
| SCHEMBL3459462 | 0.89 | — | — | |
| SCHEMBL3459610 | 0.86 | MEN1 (0.36) | MEN1KMT2ATDP1 | |
| SCHEMBL17598855 | 0.84 | — | — | |
| SCHEMBL3459237 | 0.84 | MEN1 (0.31) | MEN1KMT2ATDP1 | |
| SCHEMBL3458492 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0693924-B1 | METHODS FOR (IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | AMERICAN BIOSCIENCE INC (US) | 2004-04-21 | — | — | EP | disclosed |
| US-5665382-A | CROSSLINKING AND SULFIDING BIOCOMPATIBLE MATERIAL | VIVORX PHARMACEUTICALS, INC. (US) | 1997-09-09 | — | — | US | disclosed |
| US-5665383-A | CROSSLINKING AND SULFIDING BIOCOMPATIBLE MATERIAL | VIVORX PHARMACEUTICALS, INC. (US) | 1997-09-09 | — | — | US | disclosed |
| EP-0693924-A4 | METHODS FOR -i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS INC (US) | 1997-08-06 | — | — | EP | disclosed |
| US-5650156-A | ENCAPSULATION OF DRUGS, MICROPARTICLES, MICROEMULSIONS, SHELL CROSSLINKED BY DISULFIDE BONDS | VIVORX PHARMACEUTICALS, INC. (US) | 1997-07-22 | — | — | US | disclosed |
| US-5639473-A | SUBJECTING AQUEOUS MEDIUM CONTAINING BIOCOMPATIBLE MATERIAL CAPABLE OF BEING CROSSLINKED BY DISULFIDE BONDS AND NUCLEIC ACID CONSTRUCT TO HIGH INTENSITY ULTRASOUND WAVES | VIVORX PHARMACEUTICALS, INC. (US) | 1997-06-17 | — | — | US | disclosed |
| US-5635207-A | SUBJECTING AQUEOUS MEDIUM CONTAINING OXYGEN BINDING PROTEIN TO HIGH INTENSITY ULTRASOUND CONDITIONS TO PROMOTE CROSSLINKING AND FORM POLYMERIC SHELL OF SPECIFIED SIZE | VIVORX PHARMACEUTICALS, INC. (US) | 1997-06-03 | — | — | US | disclosed |
| US-5498421-A | IN A POLYMERIC SHELL CONTAINING SULFHYDRYL AND/OR DISULFIDE GROUPS | VIVORX PHARMACEUTICALS, INC. (US) | 1996-03-12 | — | — | US | disclosed |
| EP-0693924-A1 | METHODS FOR $i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS, INC. (US) | 1996-01-31 | — | — | EP | disclosed |
| WO-1994018954-A1 | METHODS FOR IN VIVO DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS, INC. (US) | 1994-09-01 | — | — | WO | disclosed |